Verastem | VSTM - Loan Capital


Verastem reported $50.32M in Loan Capital for its fiscal quarter ending in March of 2024.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
AstraZeneca USD 26.14B 19.58B Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Cytokinetics USD 1.12B 957.23M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Incyte USD 30.2M 5.17M Dec/2025
Laboratory Of America USD 5.15B 800K Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
TG Therapeutics USD 245.64M 305K Dec/2025
Verastem USD 50.32M 10.23M Mar/2024